Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

NCT00541437 ·Status: COMPLETED

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

NCT00491725 ·Status: COMPLETED ·Phase: PHASE4

A Study of Effect of LY3556050 on Metformin in Healthy Participants

NCT05615467 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.

NCT01089205 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes

NCT01968265 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State

NCT03939143 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions.

NCT01089192 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes

NCT01885260 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants

NCT02846506 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy

NCT01340664 ·Status: COMPLETED ·Phase: PHASE2

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

NCT01890629 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.

NCT05760456 ·Status: UNKNOWN ·Phase: PHASE3

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

NCT05550129 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

NCT00798161 ·Status: COMPLETED ·Phase: PHASE3

Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions

NCT00832481 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes

NCT00971243 ·Status: COMPLETED ·Phase: PHASE2

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

NCT01037842 ·Status: COMPLETED ·Phase: PHASE3

Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

NCT01787396 ·Status: COMPLETED ·Phase: PHASE3

Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks

NCT01819272 ·Status: COMPLETED ·Phase: PHASE2

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

NCT01762046 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin

NCT02926950 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy

NCT01051011 ·Status: TERMINATED ·Phase: PHASE3

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

NCT02167061 ·Status: COMPLETED ·Phase: PHASE1

Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea

NCT01355718 ·Status: COMPLETED

Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus

NCT05281029 ·Status: UNKNOWN